company

CURE AS

5015 BERGEN

Return on Equity
60,52 %
Current Ratio
2,14
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue13 874 000
Net Income1 892 000
Total Assets5 877 000
Total Equity3 126 000
Income (NOK)2022
Revenue13 874 000
Expenditure11 425 000
Operating Profit2 450 000
Financial Income0
Financial Costs21 000
Financial Balance−21 000
Earnings Before Tax2 429 000
Tax538 000
Net Income1 892 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets5 877 000
Total Assets5 877 000
Total Retained Equity3 096 000
Total Equity3 126 000
Total Long-Term Debt0
Total Current Debt2 751 000
Total Equity and Debt5 877 000
Cash flow (NOK)2022
Sales Income13 874 000
Other Income0
Revenue13 874 000
Cost of Goods Sold624 000
Salary Costs6 478 000
Depreciation0
Impairment0
Expenditure11 425 000
Operating Profit2 450 000
Financial Income0
Financial Costs21 000
Financial Balance−21 000
Dividends0
Net Income1 892 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank3 589 000
Total Current Assets5 877 000
Total Assets5 877 000
Total Equity3 126 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors505 000
Unpaid Taxes1 062 000
Dividends0
Other Current Debt649 000
Total Current Debt2 751 000
Total Equity and Debt5 877 000
Financial indicators2022
Return on Equity60,52 %
Debt-to-Equity Ratio0
Operating Profit Margin17,66 %
Current Ratio2,14
Quick Ratio2,14
Equity Ratio0,53
Gross Profit Margin95,5 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English